CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer-Reference-Cited by-同舟云学术

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

Published:2019-01-21 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Zhao Zi-Ming,Yost Susan E.,Hutchinson Katherine E.,Li Sierra Min,Yuan Yate-Ching,Noorbakhsh Javad,Liu Zheng,Warden Charles,Johnson Radia M.,Wu Xiwei,Chuang Jeffrey H.,Yuan Yuan

Funder

Stop Cancer

NIH K-12 Career Development Award

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5290-4.pdf

Reference54 articles.

1. Collignon J, Lousberg L, Schroeder H, Jerusalem G. Triple-negative breast cancer: treatment challenges and solutions. Breast Cancer. 2016;8:93.

2. Zeichner SB, Terawaki H, Gogineni K. A review of systemic treatment in metastatic triple-negative breast cancer. Breast Cancer. 2016;10:BCBCR. S32783.

3. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67.

4. Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2014.

5. Lehmann BD, Jovanovic B, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA. Refinement of triple-negative breast Cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS One. 2016;11(6):e0157368.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, biological evaluation, network pharmacology, and molecular docking of benzophenone as antitumor agents;Journal of Molecular Structure;2024-09

2. Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer;Journal of Medicinal Chemistry;2024-08-20

4. Artificial Intelligence in Obstetrics and Gynecology: Transforming Care and Outcomes;Cureus;2024-07-17

5. Diagnosis of cardiotocographic sinusoidal patterns by spectral analyses;Biomedical Signal Processing and Control;2024-07